| Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis MF Bustamante, R Garcia-Carbonell, KD Whisenant, M Guma Arthritis research & therapy 19, 1-12, 2017 | 365 | 2017 |
| Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis M Comabella, M Fernández, R Martin, S Rivera-Vallvé, E Borrás, C Chiva, ... Brain 133 (4), 1082-1093, 2010 | 307 | 2010 |
| A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis M Comabella, JD Lünemann, J Rio, A Sanchez, C Lopez, E Julia, ... Brain 132 (12), 3353-3365, 2009 | 232 | 2009 |
| Genome-wide scan of 500 000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis M Comabella, DW Craig, C Morcillo-Suárez, J Río, A Navarro, ... Archives of neurology 66 (8), 972-978, 2009 | 147 | 2009 |
| Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis MF Bustamante, PG Oliveira, R Garcia-Carbonell, AP Croft, JM Smith, ... Annals of the rheumatic diseases 77 (11), 1636-1643, 2018 | 135 | 2018 |
| NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis S Malhotra, J Río, E Urcelay, R Nurtdinov, MF Bustamante, O Fernández, ... Brain 138 (3), 644-652, 2015 | 114 | 2015 |
| Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy AD Bendala Estrada, J Calderón Parra, E Fernández Carracedo, ... BMC infectious diseases 21, 1-23, 2021 | 72 | 2021 |
| Design of an anti-inflammatory diet (ITIS diet) for patients with rheumatoid arthritis MF Bustamante, M Agustín-Perez, F Cedola, R Coras, R Narasimhan, ... Contemporary clinical trials communications 17, 100524, 2020 | 69 | 2020 |
| Headache during SARS‐CoV‐2 infection as an early symptom associated with a more benign course of disease: a case–control study A Gonzalez‐Martinez, V Fanjul, C Ramos, J Serrano Ballesteros, ... European Journal of Neurology 28 (10), 3426-3436, 2021 | 59 | 2021 |
| Implication of the toll‐like receptor 4 pathway in the response to interferon‐β in multiple sclerosis MF Bustamante, N Fissolo, J Río, C Espejo, C Costa, MJ Mansilla, ... Annals of neurology 70 (4), 634-645, 2011 | 56 | 2011 |
| Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis S Malhotra, MF Bustamante, F Pérez-Miralles, J Rio, MC Ruiz de Villa, ... PloS one 6 (8), e23634, 2011 | 55 | 2011 |
| Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental … N Fissolo, C Costa, RN Nurtdinov, MF Bustamante, V Llombart, ... Journal of neuroinflammation 9, 1-13, 2012 | 44 | 2012 |
| Baseline gene expression signatures in monocytes from multiple sclerosis patients treated with interferon-beta MF Bustamante, RN Nurtdinov, J Río, X Montalban, M Comabella PLoS One 8 (4), e60994, 2013 | 35 | 2013 |
| HLA class I and II alleles and response to treatment with interferon-beta in relapsing–remitting multiple sclerosis M Comabella, M Fernández-Arquero, J Río, A Guinea, M Fernández, ... Journal of neuroimmunology 210 (1-2), 116-119, 2009 | 35 | 2009 |
| Gender-associated differences of perforin polymorphisms in the susceptibility to multiple sclerosis M Camina-Tato, C Morcillo-Suárez, MF Bustamante, I Ortega, A Navarro, ... The Journal of immunology 185 (9), 5392-5404, 2010 | 30 | 2010 |
| Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β MF Bustamante, C Morcillo-Suárez, S Malhotra, J Rio, L Leyva, ... Neuroimmunology & Neuroinflammation 2 (5), e154, 2015 | 28 | 2015 |
| SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis S Malhotra, J Castilló, MF Bustamante, A Vidal-Jordana, Z Castro, ... Multiple Sclerosis Journal 19 (5), 524-531, 2013 | 27 | 2013 |
| Orchestrating innate immune responses in multiple sclerosis: molecular players M Fernández, X Montalban, M Comabella Journal of neuroimmunology 225 (1-2), 5-12, 2010 | 27 | 2010 |
| IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis S Malhotra, C Morcillo-Suárez, D Brassat, R Goertsches, J Lechner-Scott, ... Journal of neuroimmunology 239 (1-2), 101-104, 2011 | 25 | 2011 |
| Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis M Camina-Tato, M Fernández, C Morcillo-Suárez, A Navarro, E Julià, ... Journal of neuroimmunology 222 (1-2), 70-75, 2010 | 20 | 2010 |
Xavier MontalbanVerified email at cem-cat.org
